Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $5.15
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development and commercialization of drugs to sensitize cancers to radiation therapy. The company is headquartered in Rockville, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.